169 related articles for article (PubMed ID: 33489206)
21. Morbidity and mortality associated with Paget's disease of bone: a population-based study.
Wermers RA; Tiegs RD; Atkinson EJ; Achenbach SJ; Melton LJ
J Bone Miner Res; 2008 Jun; 23(6):819-25. PubMed ID: 18269308
[TBL] [Abstract][Full Text] [Related]
22. Primary hyperparathyroidism associated with multiple myeloma.
Goto S; Yoshioka M; Nagai K; Abe A; Murakawa E; Yamazaki N; Koyama T; Sekiya M
Intern Med; 1995 Oct; 34(10):988-91. PubMed ID: 8563101
[TBL] [Abstract][Full Text] [Related]
23. [The association of a myeloma and Paget's disease (author's transl)].
Carcassonne Y; Bouvenot G; Gastaut JA; Sebahoun G
Ann Med Interne (Paris); 1979; 130(3):177-84. PubMed ID: 434730
[TBL] [Abstract][Full Text] [Related]
24. [The usefulness of biochemical markers of bone remodelling in the diagnosis and follow-up of Paget's disease of bone, primary hyperparathyroidism, tumoral hypercalcemia and postmenopausal osteoporosis. I. The markers of bone formation].
de la Piedra Gordo C; Torres Jiménez R
An Med Interna; 1990 Sep; 7(9):480-6. PubMed ID: 2103291
[TBL] [Abstract][Full Text] [Related]
25. [PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia].
Scharla SH; Pecherstorfer M; Lempert UG; Minne HW; Sarrach M; Baumgartner G; Ziegler R
Med Klin (Munich); 1991 Apr; 86(4):186-9. PubMed ID: 2056982
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
de la Piedra Gordo C; Torres Jiménez R
An Med Interna; 1990 Oct; 7(10):534-8. PubMed ID: 2104101
[TBL] [Abstract][Full Text] [Related]
27. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Coukell AJ; Markham A
Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
[TBL] [Abstract][Full Text] [Related]
28. [Development of primary hyperparathyroidism in the follow-up of a patient with Paget's disease].
Spivacow FR
Medicina (B Aires); 2009; 69(1 Pt 2):173-6. PubMed ID: 19414302
[TBL] [Abstract][Full Text] [Related]
29. Coincidence of Paget disease of bone and primary hyperparathyroidism.
Wilczek H; Kanka J
Sb Lek; 1993; 94(3):213-7. PubMed ID: 7973415
[TBL] [Abstract][Full Text] [Related]
30. Renal Cell Carcinoma Metastasized to Pagetic Bone.
Ramirez A; Liu B; Rop B; Edison M; Valente M; Burt J
Cureus; 2016 Aug; 8(8):e737. PubMed ID: 27660736
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
van Breukelen FJ; Bijvoet OL; Frijlink WB; Sleeboom HP; Mulder H; van Oosterom AT
Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia syndrome. Coexisting hyperthyroidism, primary hyperparathyroidism and cancer of the gallbladder.
Barut I; Tarhan OR; Cerci C; Karahan N
Saudi Med J; 2005 Jul; 26(7):1119-21. PubMed ID: 16047066
[TBL] [Abstract][Full Text] [Related]
33. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
Delmas PD; Demiaux B; Malaval L; Chapuy MC; Edouard C; Meunier PJ
J Clin Invest; 1986 Mar; 77(3):985-91. PubMed ID: 3485113
[TBL] [Abstract][Full Text] [Related]
34. [Primary hyperparathyroidism in a patient with Paget's bone disease].
Guijarro de Armas MG; Pavón de Paz I; Zubieta Tabernero J; Civantos Modino S; Montaño Martínez JM; Díaz Guardiola P
Endocrinol Nutr; 2010 Apr; 57(4):170-3. PubMed ID: 20381437
[No Abstract] [Full Text] [Related]
35. Thirty cases of concurrent Paget's disease and primary hyperparathyroidism: sex distribution, histomorphometry, and prediction of the skeletal response to parathyroidectomy.
Gutteridge DH; Gruber HE; Kermode DG; Worth GK
Calcif Tissue Int; 1999 Dec; 65(6):427-35. PubMed ID: 10594160
[TBL] [Abstract][Full Text] [Related]
36. Paget's Disease: Skeletal Manifestations and Effect of Bisphosphonates.
Kang H; Park YC; Yang KH
J Bone Metab; 2017 May; 24(2):97-103. PubMed ID: 28642853
[TBL] [Abstract][Full Text] [Related]
37. Monostotic Paget's disease of bone - literature review and case report.
Wysiński P; Krajewska-Włodarczyk M
Reumatologia; 2019; 57(3):167-172. PubMed ID: 31462833
[TBL] [Abstract][Full Text] [Related]
38. [Diphosphonates in the treatment of hypercalcemia].
Delmas PD; Meunier PJ
Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
[TBL] [Abstract][Full Text] [Related]
39. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
Mangham DC; Davie MW; Grimer RJ
Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
[TBL] [Abstract][Full Text] [Related]
40. A Case Report of Bone Paget's Disease with Concurrent Psoriasis and Positive Celiac Serology.
Sabooniha F
Curr Med Imaging; 2023 Mar; ():. PubMed ID: 37018522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
